BCA
OM icon

Berman Capital Advisors’s Outset Medical OM Stock Holding History

Berman Capital Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$11K Buy
+15
New +$10.2K ﹤0.01% 1157

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Berman Capital Advisors's OM Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Outset Medical (OM) in Q3 2021: 15 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1157 among its holdings.

142 funds tracked by Wall St. Rank hold OM as of Q3 2021.

  • Berman Capital Advisors held 15 shares of Outset Medical worth $11K as of Q3 2021.
  • Outset Medical was a new Berman Capital Advisors position in Q3 2021.
  • Outset Medical made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1157 holding.
  • 142 funds tracked by Wall St. Rank held Outset Medical as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.